PMID: 4292958Jul 1, 1967Paper

The margin of safety of neuromuscular transmission

The Journal of Physiology
W D Paton, D R Waud

Abstract

1. The margin of safety for neuromuscular transmission in the tibialis and sartorius muscles of the cat has been determined by measuring the ratio by which end-plate depolarization produced by succinylcholine, decamethonium, octamethonium or iodocholine is antagonized, in the presence of neuromuscular block produced by tubocurarine, gallamine or DF-596. The estimate of the margin of safety was independent of the particular drugs chosen for the measurement.2. To produce threshold block to indirect stimulation once every 10 sec, a fractional occupancy by the antagonist of 0.76 +/- 0.05 (S.D.) was required; for nearly complete block, an occupancy of 0.917 +/- 0.16 (S.D.) was required. These figures correspond to factors of safety of 4.1 and 12 for the most sensitive and the most resistant groups of fibres respectively.3. The interaction between the agonists and the antagonists, when tested over a wide range of dosage, did not conform with the conditions of full competitive equilibrium. It was concluded that this arose, not because of some interfering non-competitive process, but because, during the relatively brief exposure to agonist, the equilibrium between the antagonist and the receptors is not significantly disturbed. An anal...Continue Reading

Citations

Mar 19, 2014·Revista española de anestesiología y reanimación·O Epemolu, A Bom
Mar 30, 2013·Autoimmunity Reviews·Paraskevi ZisimopoulouSocrates J Tzartos
Dec 17, 1997·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S SchiereJ M Wierda
Jul 8, 2005·Thoracic Surgery Clinics·Kemp H Kernstine
Nov 11, 1999·European Journal of Pharmacology·A ChristopoulosE E El-Fakahany
Jan 1, 1994·Pharmacology & Toxicology·D R Bevan
Jan 11, 2000·Pharmacology & Toxicology·M J de Oliveira, A C Oliveira
Oct 1, 1979·Neuropharmacology·J P Gallagher, P Shinnick-Gallagher
Jan 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D G WhalleyN M Bedocs
May 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·A Baraka
Jan 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·F Donati
Jan 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M Naguib, M Abdulatif
Jan 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M Naguib, M Abdulatif
Nov 1, 1987·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·C E SmithD R Bevan
Feb 1, 1993·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D R BevanF Donati
May 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·F Donati
Mar 1, 1986·Canadian Anaesthetists' Society Journal·M NaguibG H Absood
Jan 1, 1985·Canadian Anaesthetists' Society Journal·W G DohertyD R Bevan
Jul 1, 1986·Canadian Anaesthetists' Society Journal·M NaguibG H Absood
Nov 1, 1986·Canadian Anaesthetists' Society Journal·M Abdulatif, M Naguib
Mar 1, 1990·Neurotoxicology and Teratology·J F Ross, G T Lawhorn
Mar 12, 2010·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Tom Heier
Mar 1, 1968·British Journal of Pharmacology and Chemotherapy·S E Freeman
May 1, 1968·British Journal of Pharmacology and Chemotherapy·W Flacke, T S Yeoh
Feb 1, 1968·British Journal of Pharmacology and Chemotherapy·W D Paton, E C Savini
Sep 28, 2012·Journal of Clinical Monitoring and Computing·Tod B Sloan
Mar 21, 1977·Journal of Neurology·G HertelA Hirsch
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·W M ValentineV R Beasley
Sep 19, 1998·Journal of Pharmacological and Toxicological Methods·V Calderone
Jan 1, 1983·European Journal of Clinical Pharmacology·A A d'HollanderJ M Desmonts
Feb 7, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Frederick J Ehlert
Jan 1, 1972·Acta Anaesthesiologica Scandinavica·A Baraka
Oct 1, 1992·Acta Anaesthesiologica Scandinavica·L I ErikssonA Johnson
Oct 1, 1995·Acta Anaesthesiologica Scandinavica·P RautomaI Kalli
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·C J Hull
Sep 1, 1993·Anaesthesia·A BarakaV Yazbeck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.